Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Northrop Grumman Expands Beavercreek, Ohio, Facility October 16, 2018 One-on-One: Terri Hiskey from Epicor on ERP November 3, 2017 Print Near Net Shape Metal Parts up to 100 Cubic Feet and 3.3 Tons November 1, 2017